Jackson Consulting Group

Sep 300 min read

Chinese Antibody Society Webinar September 28, 2024): The rise, fall and resurgence of ADCs (Slide Presentation)

Sep 226 min read

The Biosecure Act and its potential impact on the US biotechnology and pharmaceutical industry from a scientist’s perspective

Dowdy Jackson, Ph.D. Jackson Consulting Group The Biosecure Act, H.R.7085 , is a bipartisan legislation that focuses on limiting US...

Jun 300 min read

Influencing ADC Performance Through Linker Design (Slide Presentation)

Jun 70 min read

Webinar: Influencing ADC Performance Through Linker Design

May 117 min read

Bispecific ADCs: A potential game changer for the next generation of ADCs

Dowdy Jackson, Ph.D. Jackson Consulting Group May 10th 2024 Abstract Antibody drug conjugates (ADCs) have become one of the most sought...

Mar 201 min read

Antibody Drug Conjugates: Are ADCs a good investment?

Recently, several high-profile ADC deals have been announced. The most prominent deal is Pfizer's acquisition of Seattle Genetics for a...

Sep 13, 20202 min read

Why The Majority of Oncology Drugs Fail In The Clinic?

Approximately 80-90% of oncology drugs that enter into clinical development (Phase I) never make it to approval (Phase III). Most...